Rallybio (NASDAQ:RLYB) 報告季度每股虧損$(0.25)，優於分析師一致預期的$(0.29)，提高了13.79%。與去年同期每股虧損$(0.50)相比，這是一項50%的改善。公司報告的季度銷售額為$38.00千，低於分析師一致預期的$75.00千，差距為49.33%。

以上內容來自Benzinga Earnings專欄，原文如下：

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 50 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $38.00 thousand which missed the analyst consensus estimate of $75.00 thousand by 49.33 percent.